• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2021, Vol. 23 ›› Issue (4): 497-501.DOI: 10.3969/j.issn.1671-2587.2021.04.019

Previous Articles     Next Articles

Effect of Fecal Microecological Transplantation Combined with Sulfasalazine on Serum Inflammatory Factors and T Cell Subsets in Patients with Ulcerative Colitis

SUN Li-li, XUE Qing   

  1. Department of Health Care, Taigong Sanatorium, Wuxi, Jiangsu 21400
  • Received:2020-03-26 Published:2021-08-18

Abstract: Objective To investigate the effects of fecal micro-ecological transplantation combined with sulfasalazine on serum inflammatory factors and T-cell subsets in patients with ulcerative colitis. Methods a study of 90 patients with UC admitted to our hospital from June 2018 to December 2019, the observation group was given fecal microecological transplantation combined with sulfasalazine, and the control group was given conventional treatment to observe serum inflammatory factors, Mayo score, T cell subsets and clinical efficacy before and after treatment in UC patients. Results The effective rate of the observation group was 95.5%. The effective rate of the observation group was significantly better than that of the control group, and the Mayo score was significantly lower than that before treatment (P<0.05). Inflammation of CRP, TNF-α, IL-6, etc. The factors were significantly decreased (P<0.05), and better than the control group (P<0.05). After treatment, the CD4+ increased and the CD4+/CD8+ ratio increased (P<0.05). The observation group was significantly higher than the control group (P<0.05). Conclusions FMT combined with sulfasalazine can improve the immune status of T cell subsets, reduce the inflammatory response, and achieve the effect of treating UC by establishing the normal intestinal flora. It has certain safety.

Key words: Fecal microecological transplantation, Ulcerative colitis, Inflammatory factors, T cell subsets

CLC Number: